Biotech and specialty pharma companies at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
11 biotech and specialty pharma companies are at SABCS 2026 — 11 with a booth in the exhibit hall. 11 of them have their own page in this guide. As of Sep 27, 2026.
Showing 1–11 of 11 organizations
| Organization | SABCS 2026 Attendance |
|---|---|
BioNTech Mainz, Germany | |
Biotech company developing mRNA and other cancer immunotherapies and antibody-drug conjugates, including a HER2-directed ADC in breast cancer trials. | Booth Exhibiting at Booth 251 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Celcuity Minneapolis, MN | |
Clinical-stage company developing gedatolisib, a PI3K/mTOR pathway inhibitor, for HR+/HER2- advanced breast cancer. | Booth Exhibiting at Booth 1510 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Greenwich LifeSciences Stafford, TX | |
Clinical-stage biotech testing GP2, a HER2 peptide immunotherapy, in the Phase III Flamingo-01 trial to prevent breast cancer from returning. | Booth Exhibiting at Booth 809 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Lantern Pharma Dallas, TX | |
Oncology drug developer using AI and genomics to speed discovery, with candidates for DNA-repair-deficient cancers including triple-negative breast cancer. | Booth Exhibiting at Booth 1153 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
LeonaBio Bothell, WA | |
Biotech developing therapies for metastatic breast cancer that no longer responds to treatment, and for ALS. | Booth Exhibiting at Booth 1431 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Olema Oncology San Francisco, CA | |
Clinical-stage company developing palazestrant, an oral estrogen receptor antagonist and degrader, in Phase 3 trials for ER+/HER2- advanced breast cancer. | Booth Exhibiting at Booth 1342 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Puma Biotechnology Los Angeles, CA | |
Markets NERLYNX (neratinib) for HER2-positive breast cancer and is testing alisertib with hormone therapy in HR+/HER2- metastatic breast cancer. | Booth Exhibiting at Booth 209 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Relay Therapeutics Cambridge, MA | |
Clinical-stage company combining computation and experiments to design small-molecule drugs, including a PI3Kα inhibitor for HR+/HER2- breast cancer. | Booth Exhibiting at Booth 1450 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
TerSera Therapeutics Deerfield, IL | |
Specialty biopharma company with oncology and rare-disease medicines, including goserelin (Zoladex) in the US. | Booth Exhibiting at Booth 808 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Corcept Therapeutics Redwood City, CA | |
Biopharma company developing cortisol-modulating medicines, including relacorilant, for endocrine disorders and cancers such as ovarian cancer. | Booth Exhibiting at Booth 1632 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Rigel Pharmaceuticals South San Francisco, CA | |
Commercial-stage biotech marketing medicines for hematology and cancer. | Booth Exhibiting at Booth 1311 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Instantly find 20 buyers from biotech and specialty pharma companies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse SABCS 2026 by
Organization type
Focus
- Patient and family support 26
- Genomic and tumor testing 22
- Hormone receptor-positive breast cancer 17
- Clinical trials and research 16
- HER2-positive breast cancer 10
- Liquid biopsy and MRD 10
- AI and data 9
- Screening and early detection 9
- Side effects and supportive care 8
- Breast surgery and biopsy 8
- Metastatic breast cancer 5
- Triple-negative breast cancer 4
- Hereditary risk and genetic testing 4
Exhibit hall
Everyone
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published exhibitor list. Submit a correction